home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> Genetic News | search  
 

Neurofibromatosis Type 1 in Genetic Counseling Practice: Recommendations of the NSGC

 
  September, 19 2007 20:12
your information resource in human molecular genetics
 
     
Neurofibromatosis Type 1 in Genetic Counseling Practice: Recommendations of the National Society of Genetic Counselors

Authors:Heather B. Radtke, Children’s Hospital of Wisconsin, Genetics Center, MS 716, 9000 W. Wisconsin Avenue, Milwaukee, WI 53201, USA

Courtney D. Sebold, Division of Genetics and Metabolic Disorders, University of Texas Health Science Center at San Antonio, San Antonio, TX, USA

Caroline Allison, Division of Genetics, Children’s Hospital Boston, Boston, MA, USA

Joy Larsen Haidle, Humphrey Cancer Center, North Memorial Medical Center, Robbinsdale, MN, USA

Gretchen Schneider, Harvard Medical School-Partners HealthCare Center for Genetics and Genomics, Boston, MA, USA

[Both Heather B. Radtke and Courtney D. Sebold contributed equally to this document]

Published in Journal of Genetic Counseling (Vol. 16, No. 4, pp. 387-407, August 2007).

Abstract:

The objective of this document is to provide recommendations for the genetic counseling of patients and families undergoing evaluation for neurofibromatosis type 1 (NF1) or who have received a diagnosis of NF1. These recommendations are the opinions of a multi-center working group of genetic counselors with expertise in the care of individuals with NF1. These recommendations are based on the committee’s clinical experiences, a review of pertinent English language medical articles, and reports of expert committees. These recommendations are not intended to dictate an exclusive course of management, nor does the use of such recommendations guarantee a particular outcome. These recommendations do not displace a health care provider’s professional judgment based on the clinical circumstances of an individual patient.

Author Contact:

Heather B. Radtke, Children’s Hospital of Wisconsin, Genetics Center, MS 716, 9000 W. Wisconsin Avenue, Milwaukee, WI 53201, USA.

Email: hradtke@chw.org

Article available online.

(C) Journal of Genetic Counseling.


Message posted by: Tressie Dalaya

print this article mail this article
Latest News
Variants Associated with Pediatric Allergic Disorder

Mutations in PHF6 Found in T-Cell Leukemia

Genetic Risk Variant for Urinary Bladder Cancer

Antibody Has Therapeutic Effect on Mice with ALS

Regulating P53 Activity in Cancer Cells

Anti-RNA Therapy Counters Breast Cancer Spread

Mitochondrial DNA Diversity

The Power of RNA Sequencing

‘Pro-Ageing' Therapy for Cancer?

Niche Genetics Influence Leukaemia

Molecular Biology: Clinical Promise for RNA Interference

Chemoprevention Cocktail for Colon Cancer

more news ...

Generated by News Editor 2.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2018 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.